TRERF1: A Potential Drug Target for Cancer and Other Diseases

Target Name: TRERF1

NCBI ID: G55809

TRERF1

TRERF1: A Potential Drug Target for Cancer and Other Diseases

TRERF1 (Rapa-1) is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer. The gene is located on chromosome 18 and encodes a non-coding RNA molecule that has been shown to play a role in the regulation of cell growth and differentiation.

Studies have shown that TRERF1 is involved in the regulation of various cellular processes, including cell cycle progression, apoptosis (programmed cell death), and stem cell maintenance. It has also been shown to be involved in the development and progression of various diseases, including cancer.

One of the key functions of TRERF1 is its role in the regulation of the cell cycle. The cell cycle is the process by which a cell grows and replicates its genetic material. TRERF1 is shown to be involved in the regulation of the length of the cell cycle, as well as the entry and exit of cells from the cell cycle. This may have important implications for the treatment of cancer, as the longer the cell cycle can be, the more likely a cell is to be resistant to chemotherapy and other treatments.

Another function of TRERF1 is its role in apoptosis. Apoptosis is a natural process that helps cells eliminate themselves when they are no longer needed or when they have been damaged beyond repair. TRERF1 is shown to be involved in the regulation of apoptosis, which may have implications for the treatment of certain diseases.

TRERF1 has also been shown to be involved in stem cell maintenance. Stem cells are a type of cell that have the ability to develop into any type of cell in the body. TRERF1 is shown to be involved in the regulation of stem cell stemness, which may have important implications for the development of stem cell-based therapies.

In addition to its role in cellular processes, TRERF1 has also been shown to be involved in the development and progression of various diseases, including cancer. For example, studies have shown that high levels of TRERF1 are associated with the development of certain types of cancer, such as lung cancer and breast cancer. Additionally,TRERF1 has also been shown to be involved in the regulation of the angiogenesis (the formation of new blood vessels) which is a critical process in the development of cancer.

Overall, TRERF1 is a gene that has been shown to be involved in a wide range of cellular processes, including cell cycle progression, apoptosis, and stem cell maintenance. Its involvement in these processes, as well as its involvement in the development and progression of various diseases, makes it a potential drug target or biomarker for the treatment of a wide range of conditions. Further research is needed to fully understand the role of TRERF1 in these processes and to develop effective treatments for those conditions.

Protein Name: Transcriptional Regulating Factor 1

Functions: Binds DNA and activates transcription of CYP11A1. Interaction with CREBBP and EP300 results in a synergistic transcriptional activation of CYP11A1

The "TRERF1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TRERF1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets